Allogene Therapeutics: 3Q Earnings Snapshot

November 5, 2019

SOUTH SAN FRANCISCO, Calif. (AP) _ Allogene Therapeutics Inc. (ALLO) on Tuesday reported a loss of $50.7 million in its third quarter.

The South San Francisco, California-based company said it had a loss of 50 cents per share.

The results beat Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for a loss of 54 cents per share.

Allogene Therapeutics shares have climbed slightly more than 7% since the beginning of the year. The stock has risen slightly more than 4% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ALLO at https://www.zacks.com/ap/ALLO